199 related articles for article (PubMed ID: 38618957)
1. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
[TBL] [Abstract][Full Text] [Related]
2. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
3. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
4. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation.
Welte T; Leitenberg D; Dittel BN; al-Ramadi BK; Xie B; Chin YE; Janeway CA; Bothwell AL; Bottomly K; Fu XY
Science; 1999 Jan; 283(5399):222-5. PubMed ID: 9880255
[TBL] [Abstract][Full Text] [Related]
5. STAT5BN642H is a driver mutation for T cell neoplasia.
Pham HTT; Maurer B; Prchal-Murphy M; Grausenburger R; Grundschober E; Javaheri T; Nivarthi H; Boersma A; Kolbe T; Elabd M; Halbritter F; Pencik J; Kazemi Z; Grebien F; Hengstschläger M; Kenner L; Kubicek S; Farlik M; Bock C; Valent P; Müller M; Rülicke T; Sexl V; Moriggl R
J Clin Invest; 2018 Jan; 128(1):387-401. PubMed ID: 29200404
[TBL] [Abstract][Full Text] [Related]
6. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.
Kelly JA; Spolski R; Kovanen PE; Suzuki T; Bollenbacher J; Pise-Masison CA; Radonovich MF; Lee S; Jenkins NA; Copeland NG; Morse HC; Leonard WJ
J Exp Med; 2003 Jul; 198(1):79-89. PubMed ID: 12835478
[TBL] [Abstract][Full Text] [Related]
7. High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Maurer B; Nivarthi H; Wingelhofer B; Pham HTT; Schlederer M; Suske T; Grausenburger R; Schiefer AI; Prchal-Murphy M; Chen D; Winkler S; Merkel O; Kornauth C; Hofbauer M; Hochgatterer B; Hoermann G; Hoelbl-Kovacic A; Prochazkova J; Lobello C; Cumaraswamy AA; Latzka J; Kitzwögerer M; Chott A; Janikova A; Pospíšilova Š; Loizou JI; Kubicek S; Valent P; Kolbe T; Grebien F; Kenner L; Gunning PT; Kralovics R; Herling M; Müller M; Rülicke T; Sexl V; Moriggl R
Haematologica; 2020; 105(2):435-447. PubMed ID: 31123029
[TBL] [Abstract][Full Text] [Related]
8. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia.
Heltemes-Harris LM; Larson JD; Starr TK; Hubbard GK; Sarver AL; Largaespada DA; Farrar MA
Oncogene; 2016 Jun; 35(26):3454-64. PubMed ID: 26500062
[TBL] [Abstract][Full Text] [Related]
9. Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.
Chen B; Yi B; Mao R; Liu H; Wang J; Sharma A; Peiper S; Leonard WJ; She JX
PLoS One; 2013; 8(2):e56600. PubMed ID: 23457589
[TBL] [Abstract][Full Text] [Related]
10. PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.
Garces de Los Fayos Alonso I; Zujo L; Wiest I; Kodajova P; Timelthaler G; Edtmayer S; Zrimšek M; Kollmann S; Giordano C; Kothmayer M; Neubauer HA; Dey S; Schlederer M; Schmalzbauer BS; Limberger T; Probst C; Pusch O; Högler S; Tangermann S; Merkel O; Schiefer AI; Kornauth C; Prutsch N; Zimmerman M; Abraham B; Anagnostopoulos J; Quintanilla-Martinez L; Mathas S; Wolf P; Stoiber D; Staber PB; Egger G; Klapper W; Woessmann W; Look TA; Gunning P; Turner SD; Moriggl R; Lagger S; Kenner L
Mol Cancer; 2022 Aug; 21(1):172. PubMed ID: 36045346
[TBL] [Abstract][Full Text] [Related]
11. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
12. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.
Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D
Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679
[TBL] [Abstract][Full Text] [Related]
13. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract][Full Text] [Related]
14. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
Yip SH; Eguchi R; Grattan DR; Bunn SJ
J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
[TBL] [Abstract][Full Text] [Related]
15. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.
Thiant S; Moutuou MM; Laflamme P; Sidi Boumedine R; Leboeuf DM; Busque L; Roy J; Guimond M
Blood Cancer J; 2017 Apr; 7(4):e551. PubMed ID: 28387753
[TBL] [Abstract][Full Text] [Related]
17. Early expression of mature αβ TCR in CD4
Laffey KG; Stiles RJ; Ludescher MJ; Davis TR; Khwaja SS; Bram RJ; Wettstein PJ; Ramachandran V; Parks CA; Reyes EE; Ferrer A; Canfield JM; Johnson CE; Hammer RD; Gil D; Schrum AG
Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2118529119. PubMed ID: 35767640
[TBL] [Abstract][Full Text] [Related]
18. BCR-ABL affects STAT5A and STAT5B differentially.
Schaller-Schönitz M; Barzan D; Williamson AJ; Griffiths JR; Dallmann I; Battmer K; Ganser A; Whetton AD; Scherr M; Eder M
PLoS One; 2014; 9(5):e97243. PubMed ID: 24836440
[TBL] [Abstract][Full Text] [Related]
19. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
[TBL] [Abstract][Full Text] [Related]
20. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
